CMPX icon

Compass Therapeutics
CMPX

6.40 USD
+0.02
0.31%
At close Updated Jan 30, 4:00 PM EST
Pre-market
After hours
6.40
0.00
0%
1 day
0.31%
5 days
9.4%
1 month
18.96%
3 months
72.04%
6 months
109.84%
Year to date
23.79%
1 year
111.92%
5 years
60.8%
10 years
60.8%
 

About: Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Employees: 35

Healthcare Biotechnology
0
Funds holding %
of 7,545 funds
Explore Fund Trends
0
Analysts bullish %
of 3 analysts
See Analyst Outlook
0
Positive news %
of 6 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™